Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2024 16:30 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces Upcoming Poster Presentation at the 29th Annual Society for Neuro-Oncology Meeting in Houston, Texas

VANCOUVER, British Columbia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new cancer...
October 25, 2024 07:30 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics to Present Research Highlighting Small-Molecule Bifunctional Inhibitors of PARP1/2 and HDAC Enzymes at the 36th EORTC-NCI-AACR Symposium in Barcelona Spain

VANCOUVER, British Columbia, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new cancer...
October 23, 2024 07:30 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces Initial Drug Candidates from Deep Docking AI Molecule Discovery Platform

VANCOUVER, British Columbia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) a biopharmaceutical company committed to advancing new cancer therapies based on novel...
September 17, 2024 07:30 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics and Variational AI Announce Drug Discovery Collaboration

VANCOUVER, British Columbia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) a biopharmaceutical company committed to advancing new cancer therapies based on novel...
August 30, 2024 16:10 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces 2024 Q2 Financial Results and Provides Corporate Update

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a...
July 26, 2024 21:25 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement

VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based...
July 22, 2024 21:55 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Provides Update on Previously Announced Private Placement

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 22, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a...
July 19, 2024 09:47 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces Second Upsizing of Private Placement

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 19, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a...
June 20, 2024 17:34 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting

VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based...
May 30, 2024 17:52 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces 2024 Q1 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX.V: RKV), (the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right